Oxford University announced Saturday that it will conduct clinical trials of the COVID-19 vaccine on children as young as 6 years old up to 17 to test the effectiveness of the vaccine in young people. Researchers employ at least 300 child volunteers to assess the level of immune response that the jabs produce in children. Oxford University and its partners are expected to begin exams this weekend at Oxford University and partner sites in London, Southampton, and Bristol. To date, the company has revealed that up to 240 children are expected to receive the COVID-19 vaccine and relapse, meningitis. At the same time Pfizer and Moderna have begun enrolling children aged 12 and over for clinical trials to see if vaccines could provide lifelong immunity to children from COVID-19 infection.
Read: Scientists are trying to develop a one-in-one vaccine as COVID-19 variants spread rapidly
Read: Covid vaccine boost shoe: second round of inoculation to begin across India today
In a statement Saturday, Oxford University said it was now enrolling volunteers from the Thames Valley area for clinical trials on children. “The purpose of this study is to test a new vaccine against COVID-19 in children and young adults aged 6-17 years,” he said. In addition, the university said, “This study will allow us to assess whether children can be protected from COVID-19 with this new vaccine called ChAdOx1 nCoV-19. It also provides valuable information on the safety aspects of the vaccine and its ability to generate good immune responses against the virus, in children and young people. “The researchers randomly assign participants to receive the COVID-19 vaccine, and perform health checks and blood tests, and gather other information about any symptoms that come after the vaccination procedure. “Participants from Black, Asian and Minority Ethnic groups are very welcome to take part in this study,” the university said.
A child must not have a ‘medical history’
Depending on the release of Oxford University, any child will be eligible to take part in the immunization test if they were living near one of the centers in Oxford, St George ‘s University Hospital, London, Southampton, in Bristol. He added that the child does not have to have an “important medical history” and must be between 6 years and 17 years and 8 months. “We will employ a total of 300 participants, up to 240 of whom will be vaccinated with the candidate vaccine ChAdOx1 nCoV-19, and up to 60 will be vaccinated under control (MenB, Bexsero),” he said. Oxford, adds the participants will be in uniform about their organization. “The data from this study can be used to support larger trials in children, and AstraZeneca can use the results to support the approval of this vaccine for use in children in the future. come, ”read the news.
Read: Angela Merkel responds to vaccine distribution critics; Ensuring a full house at venues by April
Read: France recommends ‘single-shot vaccine’ for COVID-19 survivors
(Image credit: Unusual image / producer)